(Q53602360)

English

Efficacy and tolerability of finasteride in symptomatic benign prostatic hyperplasia: a primary care study. Primary Care Investigator Study Group.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/9152564

Efficacy and tolerability of finasteride in symptomatic benign prostatic hyperplasia: a primary care study. Primary Care Investigator Study Group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/9152564

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

author name string

Tenover JL

1

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/9152564

Pagano GA

2

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/9152564

Morton AS

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/9152564

Liss CL

4

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/9152564

Byrnes CA

5

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/9152564

publication date

1 March 1997

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/9152564

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/9152564

19

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/9152564

2

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/9152564

243-258

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/9152564

The development of human benign prostatic hyperplasia with age

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Benign prostatic hyperplasia treated by castration or the LH-RH analogue buserelin: a report on 6 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of a new quality of life questionnaire for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. The Scandinavian BPH Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of finasteride on health-related quality of life in men with symptomatic benign prostatic hyperplasia. Finasteride Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, tolerability, and effect on health-related quality of life of finasteride versus placebo in men with symptomatic benign prostatic hyperplasia: a community based study. CUSP Investigators. Community based study of Proscar

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of finasteride on prostate-specific antigen in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980113-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(97)80113-0

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/9152564

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/9152564

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53602360&oldid=1507720872"